A scientist scheduled a talk at the NIH this year. Purely scientific content. The talk was cancelled because a new process now requires all speakers to be cleared by a political appointee. That detail is not a side story. It is the whole story.
The headline numbers are significant: 16 of the NIH's 27 institute directors are vacant, an NIH division lost roughly two-thirds of its staff, and the White House has been blocking agencies from spending money Congress already appropriated for fiscal 2026. But those numbers describe the wreckage. They do not explain the mechanism producing it.
The Budget Won. The Science Lost Anyway.
Here is what makes this situation methodologically interesting, and alarming. In January 2026, Congress rejected the administration's proposals to cut the NSF by more than 50% and the NIH by nearly 40%. That is a genuine legislative check. Republicans controlling Congress resisted their own president on science funding, which tells you either that research money is deeply embedded in their districts or that some of them grasped what stripping $19 billion from the NIH would actually mean for American medicine.
And yet the OMB, under Russell Vought, has been delaying or blocking the release of those already-approved funds. An executive order from last August allowed political appointees to review all grant decisions and prohibited funding for research deemed contrary to "anti-American values." This week, the Office of Personnel Management's Schedule Policy/Career classification took effect, reclassifying grant-making employees at NIH and NSF into a category with no due process protections. A political administration can now hire, fire, and direct the people deciding which science gets funded.
Think of the peer review process as a kind of error-correction system, the same function that makes science self-correcting over time. You submit your work, experts in your field evaluate the methodology, and funding follows the strongest science. What the administration has done is insert a political filter upstream of that system. The filter does not evaluate methods or data; it evaluates ideological alignment. Targeted areas include HIV prevention, substance use harm reduction, health equity research, and studies on how different populations' immune systems respond to disease. These are not fringe research programs. They are the foundation of applied public health.
The Philanthropy Argument Collapses Quickly
The administration's defenders argue the NIH should focus on evidence-based research rather than ideological agendas. I will grant them this: political influence in science funding predates this administration, and it has never been a clean system. Funding priorities always reflect some mix of public health urgency, congressional earmarks, and institutional inertia.
But that observation makes the current situation worse, not better. We are not comparing an imperfect peer review system against a pristine political alternative. We are comparing a system with known, correctable flaws against one where a single political appointee can cancel a talk about immune response because they did not like the speaker's research area.
Private philanthropy cannot substitute here. The NIH budget for fiscal 2026 is $48.7 billion, roughly 80% of which flows to universities and research institutions. The entire annual budget of the Gates Foundation is under $9 billion. There is no philanthropic solution at this scale, and philanthropists are themselves reluctant to step in because many depend on federal contracting relationships they cannot afford to risk.
The solution is specific: Congress must require that grant-making decisions at NIH and NSF be made exclusively by scientists with relevant expertise and must explicitly prohibit political appointee review of individual grants. Preserving budget numbers while allowing administrative control of the process is preservation in name only. The peer review system produces knowledge. What replaced it this week produces loyalty tests.
